Anti-™88B/ ™EM88B monoclonal antibody

Anti-™88B/ ™EM88B antibody for FACS & in-vivo assay

Target products collectionGo to ™EM88B/™EM88B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1842-Ab-1/ GM-Tg-hg-MP1842-Ab-2Anti-Human ™EM88B monoclonal antibodyHuman
GM-Tg-rg-MP1842-Ab-1/ GM-Tg-rg-MP1842-Ab-2Anti-Rat ™EM88B monoclonal antibodyRat
GM-Tg-mg-MP1842-Ab-1/ GM-Tg-mg-MP1842-Ab-2Anti-Mouse ™EM88B monoclonal antibodyMouse
GM-Tg-cynog-MP1842-Ab-1/ GM-Tg-cynog-MP1842-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM88B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1842-Ab-1/ GM-Tg-felg-MP1842-Ab-2Anti-Feline ™EM88B monoclonal antibodyFeline
GM-Tg-cang-MP1842-Ab-1/ GM-Tg-cang-MP1842-Ab-2Anti-Canine ™EM88B monoclonal antibodyCanine
GM-Tg-bovg-MP1842-Ab-1/ GM-Tg-bovg-MP1842-Ab-2Anti-Bovine ™EM88B monoclonal antibodyBovine
GM-Tg-equg-MP1842-Ab-1/ GM-Tg-equg-MP1842-Ab-2Anti-Equine ™EM88B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1842-Ab-1/ GM-Tg-hg-MP1842-Ab-2; GM-Tg-rg-MP1842-Ab-1/ GM-Tg-rg-MP1842-Ab-2;
GM-Tg-mg-MP1842-Ab-1/ GM-Tg-mg-MP1842-Ab-2; GM-Tg-cynog-MP1842-Ab-1/ GM-Tg-cynog-MP1842-Ab-2;
GM-Tg-felg-MP1842-Ab-1/ GM-Tg-felg-MP1842-Ab-2; GM-Tg-cang-MP1842-Ab-1/ GM-Tg-cang-MP1842-Ab-2;
GM-Tg-bovg-MP1842-Ab-1/ GM-Tg-bovg-MP1842-Ab-2; GM-Tg-equg-MP1842-Ab-1/ GM-Tg-equg-MP1842-Ab-2
Products NameAnti-™EM88B monoclonal antibody
Formatmab
Target Name™EM88B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-™EM88B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ™88B/ ™EM88B VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1842
    Target Name™EM88B
    Gene ID643965,320587,680723,100427005,100684204,101085789,767837,100629449
    Gene Symbol and SynonymsA230069A22Rik,™EM88B
    Uniprot AccessionA6NKF7,Q0VD38
    Uniprot Entry Name™88B_HUMAN,™88B_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000205116
    Target ClassificationN/A

    The target: ™EM88B, gene name: ™EM88B, also named as . Predicted to enable PDZ domain binding activity. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.